Health And Medicine
-
Ask an Expert: What you need to know about the omicron variant wave
Dr. William Schaffner, an internationally renowned infectious disease specialist and public health expert, shares what you should know about the latest COVID-19 variant wave, including information about breakthrough symptoms for the vaccinated population. Read MoreJan 14, 2022
-
Study sets framework for precision surveillance of colorectal cancer
A team of Vanderbilt researchers led by Ken Lau has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Read MoreJan 7, 2022
-
Vanderbilt scientist’s team project wins $55,000 to research fundamental cell behavior
Lars Plate wins $55,000 from Scialog to further collaborative research on cell behavior. Read MoreJan 6, 2022
-
Study explores how bacteria become drug resistant
Vanderbilt researchers have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Read MoreJan 6, 2022
-
Study of fully vaccinated patients with cancer who had breakthrough COVID-19 shows 13% mortality rate
New research finds that fully vaccinated patients with cancer who had breakthrough COVID-19 infections remained at high risk for hospitalization and death. Read MoreDec 24, 2021
-
Vanderbilt extends its longest ongoing drug discovery agreement with pharmaceutical company through 2023
Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. Read MoreDec 21, 2021
-
Study finds pixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stroke prevention, reduced bleeding complications
There is strong evidence that the medication apixaban (Eliquis) is preferable to rivaroxaban (Xarelto) for stoke prevention in patients with atrial fibrillation (AF), with both reduced rates of severe bleeding complications as well as strokes, according to study published Dec. 21 in JAMA. Read MoreDec 21, 2021
-
“Atlas” of lung development may aid efforts to heal premature lungs
Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time. Read MoreDec 20, 2021
-
Study finds similar success rates with two devices for breathing tube placement
Two devices for placing a breathing tube during critical illness had similar success rates for intubation on the first attempt, according to a study published Dec. 8 in JAMA. Read MoreDec 15, 2021
-
Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization
The U.S. Food and Drug Administration granted emergency use authorization Dec. 8 to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination that protects against COVID-19, discovered last year at Vanderbilt University Medical Center. Read MoreDec 10, 2021
-
McLean elected as 2021 National Academy of Inventors Fellow
John McLean, Stevenson Professor of Chemistry and director of the Center for Innovative Technologies, has been elected a 2021 fellow of the National Academy of Inventors. Read MoreDec 8, 2021
-
A potential new approach for the treatment of schizophrenia
Researchers discover how a protein may treat schizophrenia, including reversing working memory deficits, a hallmark of schizophrenia for which there is currently no treatment. Read MoreDec 8, 2021
-
Ask An Expert: What is multisystem inflammatory syndrome in children (MIS-C) and what are the symptoms?
Dr. Sophie Katz, assistant professor of pediatric infectious diseases and associate medical director of the Pediatric Antimicrobial Stewardship Program, describes the symptoms and treatment of multisystem inflammatory syndrome in children (MIS-C). Read MoreDec 6, 2021
-
Ask an Expert: What do we know about the omicron variant?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what is known about the omicron variant and provides reminders on how to stay protected this season. Read MoreDec 3, 2021
-
Gene discoveries give new hope to people who stutter
New research shows the potential to identify therapeutic directions that could improve outcomes for people who stutter. Read MoreDec 2, 2021
-
Calipari named Dean’s Faculty Fellow
Erin Calipari, assistant professor of pharmacology and a member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. Read MoreNov 30, 2021
-
Watch: Lab-to-Table Conversations: “The Science of Beer” featuring biochemistry faculty and beer science alumni
Vanderbilt alumni and the founders of Jackalope Brewing Co. and Yazoo Brewing Co. will join Vanderbilt researchers for a Dec. 16 virtual discussion about beer and fermentation science. Read MoreNov 30, 2021
-
Jon Kaas receives Society for Neuroscience’s highest honor for pathbreaking cerebral cortex research
Distinguished psychology professor Jon Kaas has received the Ralph W. Gerard Prize in Neuroscience, the highest recognition from the Society for Neuroscience, for his pathbreaking work in illuminating the structure and function of the cerebral cortex and plasticity in the developing and adult brain. Read MoreNov 23, 2021
-
Burkewitz awarded $100,000 to conduct longevity research at the cellular level
Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Read MoreNov 22, 2021
-
Five from VUMC among most highly cited researchers
Five Vanderbilt faculty members have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read MoreNov 18, 2021